[Update Cardiac Support and Assist Therapies]
- PMID: 32191969
- DOI: 10.1055/a-0853-4028
[Update Cardiac Support and Assist Therapies]
Erratum in
-
[Correction: Update Cardiac Support and Assist Therapies].Anasthesiol Intensivmed Notfallmed Schmerzther. 2020 May;55(5):288. doi: 10.1055/a-1155-0240. Epub 2020 May 12. Anasthesiol Intensivmed Notfallmed Schmerzther. 2020. PMID: 32396942 German. No abstract available.
Abstract
The management of acute and chronic heart failure utilizes various different techniques and medical devices. Different mechanical chest compression devices (mCPR), intraaortic balloon pump, catheter-based heart pumps like Impella®, and different kinds of ECLS/ECMO are mainly used as bridge to recovery. Venovenous ECMO gained wide acceptance after the CESAR trial. Venoarterial ECMO plays an increasing role as extracorporeal CPR (eCPR). Newer concepts include venovenoarterial ECMO and the combination of ECMO and Impella. Principles and limitations of these concepts are discussed. Surgically implanted devices that include left and right ventricular assist devices (LVAD, RVAD), biventricular VADs and the total artificial heart (TAH) are commonly used as bridge to transplant or destination therapies. Quality of life must be considered in the use of the devices, as the life-saving devices come with restrictions in the patients' lives.
Die Verwendung von kardialen Ersatz- und Unterstützungsverfahren ist heute klinischer Alltag. Anästhesisten sollten mit diesen Systemen gut vertraut sein – denn sowohl bei deren Implantation als auch bei der Betreuung der betroffenen Patienten spielt der Anästhesist eine wichtige Rolle. Der Beitrag erläutert die Funktionsweise, die Indikationen und die Therapieziele der wichtigsten Herzersatz- und -unterstützungssysteme.
Georg Thieme Verlag KG Stuttgart · New York.
Conflict of interest statement
MeSH terms
LinkOut - more resources
Full Text Sources
Medical